Web Trader MT5 
Investments in the health-care sector require an understanding of the unique dynamics of drug development and regulatory approvals.
Ever wonder what happens behind the scenes before a life-saving medicine finally hits the pharmacy shelves?
If you are learning how to invest in pharmaceutical companies, you must understand this complex process. The wider healthcare industry offers unique opportunities, driven by steady global demand for healthcare, rapid innovation, and incredibly long product life cycles.
To understand how to invest in pharmaceuticals, you have to realize that this space is broken up into different entities. Pharmaceutical companies are very different from biotech companies.
Pharmaceuticals are large, established companies that make and sell drugs that are already approved, to a world-wide market. Biotech companies, on the other hand, tend to be smaller and are more heavily committed to early-stage research and experimental therapies.
This guide aims to explain exactly how pharmaceutical stocks work, what economic factors influence their market value and the various ways that you can begin investing in them.
Quick Answer
Investing in pharmaceutical companies means investing in shares of companies that produce and sell medicines or gaining exposure through diversified health care funds. These stocks are influenced by drug development pipelines, regulatory approvals, and patent protections, unlike many other sectors.
What Are Pharmaceutical Stocks?
Pharmaceutical stocks are large, established companies that develop, manufacture and distribute approved medical treatments on a worldwide basis.
When you buy shares in a pharmaceutical company, you are investing in a big business. They tend to be mature businesses with a portfolio of approved medical products generating stable revenues.
It is very important to distinguish these large entities from their biotech counterparts. Both are part of the healthcare ecosystem but they have different business models. Pharma companies are well established and profitable businesses with large global distribution networks.
But biotech companies are usually earlier stage and research-driven, using cutting-edge biological processes to develop new therapies. If you want to get into the research-heavy side of the industry, you might want to look into biotech stocks.
To get ahead in this industry you need to understand a few key concepts:
- Drug Development Pipeline: The complete array of drugs that a company is currently engaged in research, testing, and attempts to bring to market.
- Regulatory Approval: The extensive review process by government agencies such as the Food and Drug Administration (FDA) to determine if a drug is safe and effective enough to be marketed.
- Patent Cliff: The point at which a company’s patent on a profitable drug expires, causing a sharp drop in revenue.
- Generic Competition: When a drug’s patent expires, cheaper, non-brand-name versions of the drug flood the market.
- Blockbuster Drug: A very popular medication that brings in huge annual revenue, usually a billion dollars or more, serving as a major financial pillar for the company.
How Do Pharmaceutical Stocks Work?
The value of a pharmaceutical stock is largely determined by the progress of its drug pipeline and the commercial success of its approved drugs.
The life cycle of medicines fully determines the economics of the pharmaceutical industry. The path from lab idea to widely distributed medicine is long and expensive and tightly controlled.
The Food and Drug Administration (FDA) outlines a rigorous multi-step process that all drugs must go through before commercialization.
Here’s a look at the drug development pipeline:
| Pipeline Stage | Description | Impact on Company |
| Research & Development (R&D) | Companies invest heavily in discovering new biological compounds and testing treatments in laboratories. | High capital expenditure with zero immediate revenue. |
| Clinical Trials | Drugs go through multiple trial phases (Phase I, II, III) on human subjects to test safety and effectiveness. | Positive trial data can boost market confidence; negative data can cause stock drops. |
| Regulatory Approval | Final trial data is submitted to regulatory bodies like the FDA for commercial approval. | Approval acts as a major catalyst, allowing the company to finally monetise the drug. |
| Commercialisation | The approved drug is manufactured, marketed, and prescribed to patients worldwide. | Generates steady revenue, protected by patents for a set number of years. |
Patent protection is very important for the sector’s revenue generation. When a company invents a new drug, they get a patent which gives them market exclusivity. It also prevents rivals copying the formula.
In this age of exclusivity, successful blockbuster drugs are big money makers. But the expiry of a patent is a drastic change. When the patent runs out, other manufacturers can legally produce their own generic versions of the drug.
Now with generics, huge pricing competition and the dreaded “patent cliff” where the revenue of the original creator for that drug drops to nothing. “So regulatory decisions and clinical trial results can be huge catalysts for stock prices.
How to Invest in Pharmaceutical Companies
Investors can gain exposure to the pharmaceutical sector in a couple ways: by buying shares of individual companies or by investing in diversified funds such as ETFs and mutual funds.
There are many different ways of entering the pharmaceutical market, each with different levels of risk and different research methods.
Individual Pharmaceutical Stocks
If you want to buy shares of individual drug companies, you have to do your homework on the specific products in their pipeline and their financial condition.
Investors can also open a standard brokerage account to research and buy shares of publicly traded pharmaceutical companies. If you are learning how to buy pharmaceutical stocks, it’s important to remember that buying single stocks concentrates your risk.
The fortunes of a single pharmaceutical company can often rest on just a handful of blockbuster drugs. Shares can suffer a big hit if a major drug fails in late-stage clinical trials or is rejected by regulators.
So, you want to really dig into a stock and see its upcoming patent expirations, how much debt they have, and the diversity of its current product pipeline.
Pharmaceutical Sector ETFs
Exchange-Traded Funds offer an opportunity to invest in a diversified basket of pharmaceutical companies at the same time, thereby diversifying the pipeline risk.
If you want to invest in pharmaceutical stocks but don’t want to risk a single company falling, a sector ETF is a very practical choice. A pharmaceutical ETF pools money from investors to buy shares in dozens of drug makers at one time.
With so many different companies in the fund, one failed drug trial with one company will not totally destroy the value of the entire fund. This provides diversified sector exposure and typically offers a smoother, less volatile investment experience than owning individual stocks.
Healthcare Mutual Funds
An actively managed healthcare mutual fund is an investment fund that seeks to invest in a select group of pharmaceutical and medical companies.
Healthcare mutual funds, like ETFs, provide diversification across the industry. But these are run by financial professionals who pick the stocks based on ongoing market analysis and medical trends.
These funds are great for diversification, but they may have different fee structures and expense ratios than passive ETFs. Sites like STARTRADER provide a wealth of market resources and charting tools to help you track wider sector trends which can be useful when determining how to distribute your portfolio among different healthcare funds.
What Are the Risks of Pharmaceutical Stocks?
Pharmaceutical investments carry their own unique risks, primarily related to regulatory hurdles, clinical trial failures, and patent expirations.
The healthcare sector is generally viewed as defensive but pharma stocks have unique risks that are not in other industries. ClinicalTrials.gov tracks data that shows that there are thousands of studies conducted around the world, but only a fraction of experimental treatments ever make it to market.
- Clinical Trial Failure: Failure at any stage of testing for drugs. If a drug turns out to be unsafe or ineffective in a late-stage trial, the years of capital that have gone into R&D are lost, which can have a major impact on future revenue potential. About 90% of drug candidates in clinical trials fail, meaning only 1 in 10 ever reaches approval.
- Patent Expiry: The loss of exclusivity and entry of cheap generic alternatives. That destroys the profits from the original drug instantly and forever.
- Regulatory Rejection: Despite clinical trial successes, regulatory agencies like the FDA can still deny approval or require additional testing before the product can hit the market.
- Pricing Pressure: Governments, insurance companies and healthcare systems are always pushing back against high drug prices, which can cut into profit margins.
- Litigation Risk . The medical industry is very litigious. Massive class-action lawsuits can arise from unforeseen side effects discovered years after a drug is commercialised.
These issues make pharmaceutical stocks notoriously volatile, particularly in the days surrounding clinical trial results or official regulatory decisions.
What Should You Consider Before Investing?
Investors should assess their risk tolerance, overall portfolio allocation and how well they understand the drug development lifecycle before investing capital.
Here’s a checklist to go over before making any investment decisions:
- Portfolio Allocation: What percent of your total investment portfolio should you invest in the healthcare sector. Too much exposure to one industry can increase overall risk.
- Risk Tolerance: Remember that although big pharma is relatively stable, it can also be very volatile depending on trial results and patent news.
- Time Horizon: The time frame for drug development is years. Pharmaceuticals usually require a long-term view to see a pipeline grow from research to commercial revenue.
- Understanding Pipelines: Understanding the nature of clinical trial phases is essential to assess the future growth potential of individual companies.
- Diversification: It may be a good idea to spread out your risk across several companies or choose a sector ETF, rather than put all your eggs on the drug pipeline of a single stock.
FAQs
Pharmaceutical companies are typically large, established companies that make money by producing and selling approved drugs. Biotech companies, on the other hand, tend to be more experimental and in the early stages of research, and may not have products on the shelves.
A patent cliff happens when a blockbuster drug no longer has a legal monopoly over the market. This opens the door for other companies to create and sell cheaper generic versions which quickly diminish the market share and revenue for the original creator.
Big catalysts include FDA approvals. An approval allows a company to finally sell a drug and make money, often sending the stock price soaring. But getting turned down, by contrast, limits growth potential and can cause the stock to plummet.
Yes, you can get exposure to this sector easily through an Exchange-Traded Fund (ETF). ETFs enable investors to achieve diversified exposure by simultaneously holding shares in different pharmaceutical companies, which helps to reduce the risk of the failure of a single company.
Conclusion
Investing in pharmaceutical companies provides a distinct opportunity to partake in the global healthcare economy.
But it requires a sound understanding of how drug development pipelines, regulatory approvals and patent protection are what fundamentally drive market value.
The industry is always innovating and has global demand, but there are inherent risks to be weighed carefully, like clinical trial failures and patent cliffs. Whether you’re digging into individual stocks or looking for broader exposure through diversified ETFs, it is important to keep a long-term perspective.
Also, focus on portfolio diversification as you navigate the pharmaceutical landscape. Perhaps a good next step would be to get acquainted with a demo account, to follow these specific market movements and to build up your understanding.
Disclaimer: This content is for educational purposes only and does not constitute investment, financial, or legal advice. CFDs are complex instruments and carry a high risk of rapid money loss due to leverage. Emerging market investments involve additional risks including currency fluctuations, limited liquidity, and regulatory changes. Any references to regulations or market structures are general in nature and subject to change. Seek independent professional advice before making any investment decisions.
Tags
Open Live Account
Please enter a valid country
No results found
No results found
Please enter a valid email
Please enter a valid verification code
1. 8-16 characters + numbers (0-9) 2. blend of letters (A-Z, a-z) 3. special characters (e.g, !a#S%^&)
Please enter the correct format
Please tick the checkbox to proceed
Please tick the checkbox to proceed
Important Notice
STARTRADER does not accept any applications from Australian residents.
To comply with regulatory requirements, clicking the button will redirect you to the STARTRADER website operated by STARTRADER PRIME GLOBAL PTY LTD (ABN 65 156 005 668), an authorized Australian Financial Services Licence holder (AFSL no. 421210) regulated by the Australian Securities and Investments Commission.
CONTINUEImportant Notice for Residents of the United Arab Emirates
In alignment with local regulatory requirements, individuals residing in the United Arab Emirates are requested to proceed via our dedicated regional platform at startrader.ae, which is operated by STARTRADER Global Financial Consultation & Financial Analysis L.L.C.. This entity is licensed by the UAE Capital Market Authority (CMA) under License No. 20200000241, and is authorised to introduce financial services and promote financial products in the UAE.
Please click the "Continue" button below to be redirected.
CONTINUEError! Please try again.
